Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
about
Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Oxidative-stress induced increase in circulating fatty acids does not contribute to phospholipase A2-dependent appetitive long-term memory failure in the pond snail Lymnaea stagnalis.Mass Spectrometry-based Lipidomics and Its Application to Biomedical ResearchSevere disturbance in the Ca2+ signaling in astrocytes from mouse models of human infantile neuroaxonal dystrophy with mutated Pla2g6Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders.Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD.Protective effect of quinacrine against glycerol-induced acute kidney injury in rats.The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairmentRegulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain.Fatting the brain: a brief of recent researchBACE1 RNAi Restores the Composition of Phosphatidylethanolamine-Derivates Related to Memory Improvement in Aged 3xTg-AD Mice.Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis.Positive and negative effects of prostaglandins in Alzheimer's disease.Mechanisms of neuronal membrane sealing following mechanical trauma.Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-β and These Lipids.Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains.Effects of Acetylcholine on β-Amyloid-Induced cPLA2 Activation in the TB Neuroectodermal Cell Line: Implications for the Pathogenesis of Alzheimer's Disease.β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling.Plasma lipids metabolism in mild cognitive impairment and Alzheimer's disease.Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.A strategy to find novel candidate anti-Alzheimer's disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants.Omega-3 polyunsaturated fatty acids do not fluidify bilayers in the liquid-crystalline state
P2860
Q30451918-51ED0C68-3865-401C-8B20-E77EBBD247EAQ33578272-811CD7F7-06B8-4B03-8440-197FF3BBF251Q35332947-C061482B-0421-42F6-941B-06516F9F2D51Q35997571-9A38172B-CB0D-4692-B725-952E63844684Q36035835-904BD375-B9DD-44EC-9C5D-CAB7A5D0BC2CQ36188186-89F4A02B-2FAE-4ED9-BF5E-790C4695DAFAQ36262805-98603034-F397-4D8F-AB4C-1FF33F7DD58FQ36428387-5BA647C4-1D67-4280-987A-8A1D5CF21613Q36989424-39F488B8-C656-483B-A9A1-3F6DEB1A8805Q37155461-797BEC76-7CE0-40ED-99A6-B27AABD0285DQ37409066-B33416F4-7D20-469E-90FE-7A7C6F0FF5A7Q38014755-DB1F570D-8804-4B74-AB8C-A66DE42801CEQ38132922-50D6A44C-F8B4-4052-82DC-E56DF264FBECQ38226141-207C6BCC-F81A-419E-B303-313A3CD550B7Q40196236-6D0494A0-AF1F-4315-ADB3-B480C5EAFB1DQ47361754-1EC0FB16-5044-4470-906C-F926471FD380Q47585631-66D72F39-38F2-4F8D-A338-FB2117F47B2EQ47705574-0AE2E421-84EA-41E7-AD9E-DC1A93A9E625Q50041775-37D4EDED-FF6F-45E7-AC1F-50B806D06F89Q54996405-D11944E1-62E3-4344-AA33-C1B47CD5FE7EQ55092298-D8F445EA-C264-4E72-8A3D-0A876507FE9CQ58618234-76640F10-DE89-4BEC-97DE-BB0E78BBF5CE
P2860
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
@ast
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
@en
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
@nl
type
label
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
@ast
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
@en
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
@nl
prefLabel
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
@ast
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
@en
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
@nl
P2093
P2860
P1476
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
@en
P2093
Agnes Simonyi
Albert Y Sun
Grace Y Sun
James C-M Lee
P2860
P304
P356
10.1111/J.1471-4159.2010.07033.X
P407
P577
2011-01-07T00:00:00Z